All posts

Converge Technology Solutions keeps Buy rating with Eight Capital

Canadian IT and Cloud Solutions provider Converge Technology Solutions (Converge Technology Solutions Stock Quote, Charts, News, Analysts, Financials TSX:CTS) saw its share price drop significantly on Wednesday, a day after reporting preliminary fourth quarter 2022 numbers. Underwhelming, was the assessment from Eight Capital analyst Christian Sgro, who delivered an update to clients on Wednesday where he maintained a “Buy” rating on the stock and a $10.00 target price.

Converge, which offers solutions such as advanced analytics, application modernization, cloud platforms, cybersecurity and digital infrastructure, announced on Tuesday preliminary financials for its Q4 2022, featuring net revenue of $765.3-$777.6 million for a year-over-year improvement of approx. 53 per cent. Adjusted EBITDA is expected at $40.8-$44.2 million, representing a year-over-year projected increase of 23 per cent.

The company said its bookings backlog grew by $52 million sequentially to $555.7 million, with the company noting the impact of ongoing supply chain challenges.

“Despite macro and short-term supply chain headwinds, we have started 2023 strong from both an order and delivery standpoint,”said Shaun Maine, CEO, in a press release. “At the same time, we invested approximately $8 million in 2022 to build out a dedicated team to accelerate the integrations of the 19 acquisitions we’ve made over the last two years. With no new acquisitions planned in the first half of 2023, we expect to demonstrate the organic strength of the business.”

Sgro said the numbers looked to be coming in below consensus, with the $771.5 million revenue midpoint comparing to the Street’s forecast at $791.5 million and Sgro’s own call at $756.9 million. Meanwhile, adjusted EBITDA at a midpoint of $42.5 million would also be below the consensus at $51.9 million and Eight Capital at $53.0 million.

Sgro called the impact of the preliminary report a negative and he noted that, as expected, management provided no further news on the previously announced strategic review.

“We continue to see the SMB end market as more resilient although it is not immune to extended sales cycles, with Converge pointing to some slipped deals. Margins and CFO missed our expectations, and we expect stable improvement in 2023 as assets are integrated and the cost base is rightsized,” Sgro wrote.

“The announced agreement to acquire the outstanding interests in REDNET could streamline conversations, in our view. The company noted that there are no plans otherwise for new acquisitions in H1/23, which will bring organic trends more clearly into focus as we move through the year,” he said.

At the time of publication, Sgro’s $10.00 target represented a projected one-year return of 83 per cent.

We Hate Paywalls Too!

At Cantech Letter we prize independent journalism like you do. And we don't care for paywalls and popups and all that noise That's why we need your support. If you value getting your daily information from the experts, won't you help us? No donation is too small.

Make a one-time or recurring donation

Tagged with: cts
Staff

Recent Posts

WELL Health inks five-year deal with Microsoft

It's become one of the biggest players in the Canadian healthcare space, now WELL Health (WELL Health Stock Quote, Chart,… [Read More]

11 hours ago

Is Thomson Reuters stock a buy right now?

Its stock has made a since last October, but is there more upside left in Thomson Reuters (Thomson Reuters Stock… [Read More]

12 hours ago

Is GOOGL still a buy?

Following a widely applauded first quarter beat, Roth MKM analyst Rohit Kulkarni has maintained his "Buy" rating on Alphabet (Alphabet… [Read More]

2 days ago

NLH has 173% upside, Echelon says

Following an acquisition, Echelon Capital Markets analyst Stefan Quenneville has maintained his "Buy" rating on Nova Leap Health (Nova Leap… [Read More]

2 days ago

Shopify upgraded to “Buy” at Citi

The stock has been flat since November, but Citi analyst Tyler Radke thinks there is now money to be made… [Read More]

2 days ago

Sabio has 400% upside, Eight Capital says

Following the company's fourth quarter results, Eight Capital analyst Kiran Sritharan has maintained his "Buy" rating on Sabio Holdings (Sabio… [Read More]

4 days ago